000 | 02953nam a2200373Ia 4500 | ||
---|---|---|---|
001 | 0000085759 | ||
005 | 20171002054338.0 | ||
006 | m u | ||
007 | cr cn||||||||| | ||
008 | 060721s2006 sz a sb i100 0 eng d | ||
020 | _z9241209372 | ||
035 | _a(CaPaEBR)ebr10137826 | ||
035 | _a(OCoLC)70830413 | ||
040 |
_aCaPaEBR _cCaPaEBR |
||
050 | 1 | 4 |
_aRA8 _b.A247 2006eb |
245 | 0 | 0 |
_aWHO Expert Committee on Specifications for Pharmaceutical Preparations _h[electronic resource] : _bfortieth report. |
260 |
_aGeneva : _bWorld Health Organization, _c2006. |
||
300 |
_ax, 461 p. : _bill. |
||
490 | 1 |
_aWHO technical report series ; _v937 |
|
500 | _a"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 24-28 October 2005"--P. vii. | ||
504 | _aIncludes bibliographical references. | ||
520 | _aThis report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies. | ||
533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2009. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
650 | 0 |
_aDrugs _xStandards _vCongresses. |
|
650 | 0 |
_aPharmacopoeias _vCongresses. |
|
650 | 0 |
_aDrugs _xQuality control _vCongresses. |
|
655 | 7 |
_aElectronic books. _2local |
|
710 | 2 | _aWorld Health Organization. | |
710 | 2 |
_aWHO Expert Committee on Specifications for Pharmaceutical Preparations _n(40th : _d2005 : _cGeneva, Switzerland) |
|
710 | 2 | _aebrary, Inc. | |
830 | 0 |
_aTechnical report series (World Health Organization) ; _v937. |
|
856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/daystar/Doc?id=10137826 _zAn electronic book accessible through the World Wide Web; click to view |
908 | _a170314 | ||
942 | 0 | 0 | _cEB |
999 |
_c74916 _d74916 |